| Q40883276 | A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus. |
| Q40532649 | Active NF-kappaB signalling is a prerequisite for influenza virus infection. |
| Q21131584 | An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link |
| Q59358390 | Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo |
| Q38922273 | Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells. |
| Q34712746 | Autophagy in herpesvirus immune control and immune escape |
| Q39917652 | Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. |
| Q38000577 | Burkitt lymphoma: the role of Epstein-Barr virus revisited |
| Q93208156 | Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma |
| Q55259946 | Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. |
| Q34861362 | Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus |
| Q36228567 | Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. |
| Q33223494 | Direct mapping of MHC class II epitopes |
| Q44013424 | Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells |
| Q40613843 | Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses |
| Q39961894 | Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export |
| Q34555263 | Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation |
| Q40526255 | Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells |
| Q47548563 | Epstein-Barr virus strain heterogeneity impairs human T-cell immunity. |
| Q34613494 | Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding |
| Q23757358 | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes |
| Q34364444 | Humanized c-Myc mouse |
| Q33677067 | Identification of MHC II-Restricted Minor Histocompatibility Antigens After HLA-Identical Stem-Cell Transplantation |
| Q35139240 | Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach |
| Q41731954 | Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection. |
| Q90449342 | Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection |
| Q50088371 | Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice |
| Q33289956 | Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy |
| Q60306812 | Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice |
| Q40871058 | Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins. |
| Q34048911 | MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells |
| Q40649977 | Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy |
| Q45355050 | Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool |
| Q28178383 | Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries |
| Q29620331 | Pancreatic cancers require autophagy for tumor growth |
| Q41602635 | Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing |
| Q34743762 | Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion |
| Q39879585 | Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response |
| Q64104879 | Progress in EBV Vaccines |
| Q40992619 | Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection. |
| Q42221268 | Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles |
| Q24812741 | Stringent doxycycline-dependent control of gene activities using an episomal one-vector system |
| Q27305136 | Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice |
| Q35018846 | Targeting c-MYC with T-cells |
| Q39026731 | Targeting high-grade B cell lymphoma with CD19-specific T cells |
| Q95931411 | The Epstein-Barr virus major tegument protein BNRF1 is a common target of cytotoxic CD4+ T cells |
| Q34624363 | The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells |
| Q33860858 | The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection |
| Q45259919 | Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens |
| Q33650689 | Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders |
| Q39715560 | Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors |